Wealthspan Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54M Buy
2,120
+9
+0.4% +$9.2K 0.8% 30
2026
Q1
$1.94M Buy
2,111
+1
+0% +$1.01K 0.68% 34
2025
Q4
$2.27M Buy
2,110
+10
+0.5% +$9.56K 0.82% 30
2025
Q3
$1.6M Hold
2,100
0.61% 36
2025
Q2
$1.64M Buy
2,100
+4
+0.2% +$3.11K 0.68% 33
2025
Q1
$1.73M Buy
2,096
+2
+0.1% +$1.66K 0.8% 30
2024
Q4
$1.62M Buy
2,094
+12
+0.6% +$9.94K 0.77% 30
2024
Q3
$1.84M Hold
2,082
0.91% 26
2024
Q2
$1.89M Hold
2,082
1.04% 22
2024
Q1
$1.62M Buy
2,082
+28
+1% +$19.9K 0.95% 22
2023
Q4
$1.2M Hold
2,054
0.84% 22
2023
Q3
$1.1M Sell
2,054
-16
-0.8% -$8.24K 0.87% 21
2023
Q2
$971K Buy
2,070
+1
+0% +$419 0.77% 23
2023
Q1
$711K Sell
2,069
-10
-0.5% -$3.37K 0.61% 31
2022
Q4
$761K Buy
2,079
+5
+0.2% +$1.77K 0.69% 27
2022
Q3
$671K Buy
2,074
+14
+0.7% +$4.44K 0.69% 31
2022
Q2
$668K Buy
2,060
+12
+0.6% +$3.6K 0.69% 28
2022
Q1
$586K Sell
2,048
-26
-1% -$6.69K 0.53% 32
2021
Q4
$573K Buy
+2,074
New +$526K 0.51% 38

Other funds holding LLY

Wealthspan Partners's LLY Position: Q2 2026 in Review

Wealthspan Partners increased its Eli Lilly (LLY) stake by 0.43% in Q2 2026, buying an estimated $9.2K and bringing the position to 2,120 shares worth $2.54M. The position accounts for 0.8% of the portfolio, ranked #30.

Wealthspan Partners first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wealthspan Partners held 2,120 shares of Eli Lilly worth $2.54M as of Q2 2026.
  • Wealthspan Partners bought 9 Eli Lilly shares in Q2 2026, an estimated $9.2K.
  • Eli Lilly made up 0.8% of Wealthspan Partners's portfolio in Q2 2026, its #30 holding.
  • Wealthspan Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wealthspan Partners's 13F filing for Q2 2026, filed 6 Aug 2026.